Summarize what the anal cancer NCCN guidelines suggest as next steps

November 4, 2025Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Next Steps Based on NCCN Guidelines for Recurrent Anal Cancer

Based on Hillel's clinical situation documented here, I need to be clear about what the document shows versus what NCCN guidelines recommend:

What Hillel's Document Shows:

According to his clinical summary, Hillel has recurrent anal squamous cell carcinoma that developed after completing standard chemoradiation (the Nigro protocol) in June 2025. His cancer initially responded well—shrinking from 10.4 cm to 0.9 cm—but then recurred by October 2025 with a ~4x2 cm ulcerative mass.

The document notes his care team is considering:

  • Multidisciplinary tumor board discussion
  • Salvage surgery versus additional radiation
  • Pain management optimization

What NCCN Guidelines Recommend:

According to NCCN Guidelines for Anal Carcinoma, salvage treatment options for recurrent disease after initial chemoradiation typically include:

  1. Salvage surgery (abdominoperineal resection) - often considered the primary option for localized recurrence
  2. Re-irradiation - may be considered in selected cases, though this carries increased toxicity risks
  3. Systemic chemotherapy - particularly if there's evidence of metastatic disease

Important Next Step:

The document specifically recommends a multidisciplinary tumor board discussion, which aligns with NCCN guidance. This team should evaluate whether Hillel is a candidate for salvage surgery, given his localized recurrence and relatively young age (37 years old).

I strongly recommend Hillel discuss these specific NCCN-recommended options with his oncology team to determine which approach is most appropriate for his individual situation.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2